Delivery Order SPE2DB22D2206-SPE2DB25FJE45
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- This federal contract award is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $26,927.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,463.77 contract is for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a completion date of March 22, 2024. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $27,841.82 firm fixed price delivery order is for the supply of ORSERDU 345 MG TABLET 30S, a medical product, with a performance period through July 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,841.82 firm fixed-price contract is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This federal contract award is for the procurement of ORSERDU 345 MG TABLET 30S medical supplies by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $83,525.46 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,684.19 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,367.28 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract issued to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJE45Delivery Order
The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal medical procurement vendor, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents one of numerous contract actions under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 7/31/25 |